Business Standard

Wednesday, February 12, 2025 | 08:20 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Popular heart drugs tainted with carcinogens face a wave of lawsuits

Millions of Americans have taken the drugs, which are at the center of a widening recall being overseen by the USFDA

The company already enjoys a 67-68 per cent share of the respiratory drugs market in India and has potential for a 14-15 per cent growth
Premium

Anna Edney and Margaret Cronin Fisk | Bloomberg
Dozens of lawsuits have been filed against drug makers and sellers over widely prescribed generic heart medications tainted with potential carcinogens, the first claims in what some lawyers expect to be a wave of litigation.
 
Millions of Americans have taken the drugs, which are at the center of a widening recall being overseen by the U.S. Food and Drug Administration, and have been for decades used to treat high blood pressure, heart failure and other common conditions.
 
A lawyer involved in an effort to combine about 50 lawsuits, including at least 27 by patients who say they contracted cancer by

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in